Balance Sheet Sharp Corporation

Equities

6753

JP3359600008

Household Electronics

Market Closed - Japan Exchange Other stock markets 01:30:00 2025-01-24 am EST			5-day change	1st Jan Change
921.40 ^JPY	-0.50%		+2.38%	-6.45%

Dec. 26	Sekisui Chemical to Begin Mass Production of Perovskite Solar Cells	MT
Dec. 26	Sekisui Chem to begin mass production of perovskite solar cells in 2027	RE

deaaff6e532d5c8f36b881c.NurNXuc5wIt18uSHNlAUuaATPKeH_qpOwB8QbPOvqwI.A46gEdZtqrssotDXUAREyNFETcLMzd0a-EphFLrE6ERS2YIZvmaM-Bqxlw

Published financial data: SHARP CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	2,262B	2,426B	2,496B	2,548B	2,322B
Total Revenues	2,262B	2,426B	2,496B	2,548B	2,322B
Cost of Goods Sold, Total	1,857B	2,005B	2,064B	2,217B	1,974B
Gross Profit	405B	421B	432B	331B	348B
Selling General & Admin Expenses, Total	330B	317B	325B	340B	349B
R&D Expenses	23.85B	20.97B	21.71B	17.01B	19.69B
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	354B	338B	347B	357B	368B
Operating Income	51.46B	83.11B	84.72B	-25.72B	-20.34B
Interest Expense, Total	-4.7B	-5.51B	-4.45B	-9.3B	-10.8B
Interest And Investment Income	4.42B	4.06B	4.13B	4.21B	6.42B
Net Interest Expenses	-279M	-1.45B	-322M	-5.08B	-4.38B
Income (Loss) On Equity Invest.	-4.08B	-16.7B	3.63B	-20.4B	8.36B
Currency Exchange Gains (Loss)	3.05B	5.55B	18.95B	17.22B	13.36B
Other Non Operating Income (Expenses)	25M	-7.33B	7.99B	3.49B	-4.08B
EBT, Excl. Unusual Items	50.17B	63.18B	115B	-30.49B	-7.08B
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-13.28B	-1.99B	461M	12.56B	3.56B
Gain (Loss) On Sale Of Assets	2.5B	4.99B	4.54B	5.86B	-75M
Asset Writedown	-3.4B	-6.42B	-22.7B	-221B	-122B
Legal Settlements	-	-	-2.76B	-	-
Other Unusual Items	-3.66B	6.69B	-4.69B	-6.42B	-11.63B
EBT, Incl. Unusual Items	32.33B	66.44B	89.8B	-239B	-138B
Income Tax Expense	17.77B	14.22B	16.04B	22.61B	12.52B
Earnings From Continuing Operations	14.56B	52.23B	73.76B	-262B	-150B
Net Income to Company	14.56B	52.23B	73.76B	-262B	-150B
Minority Interest	-831M	1.04B	234M	814M	104M
Net Income - (IS)	13.73B	53.26B	73.99B	-261B	-150B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	13.73B	53.26B	73.99B	-261B	-150B
Net Income to Common Excl. Extra Items	13.73B	53.26B	73.99B	-261B	-150B
Per Share Items
Net EPS - Basic	22.47	87.2	121.14	-407.31	-230.99
Basic EPS - Continuing Operations	22.47	87.2	121.14	-407.31	-230.99
Basic Weighted Average Shares Outstanding	611M	611M	611M	640M	649M
Net EPS - Diluted	22.47	87.2	121.14	-407.31	-230.99
Diluted EPS - Continuing Operations	22.47	87.2	121.14	-407.31	-230.99
Diluted Weighted Average Shares Outstanding	635M	611M	611M	640M	649M
Normalized Basic EPS	49.98	66.34	118.02	-28.48	-6.66
Normalized Diluted EPS	48.07	66.34	118.02	-28.48	-6.66
Dividend Per Share	18	30	40	-	-
Payout Ratio	109.49	20.61	24.75	-9.36	-0.02
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	124B	155B	157B	64.08B	45.87B
EBITA	51.46B	83.11B	84.72B	-25.72B	-20.34B
EBIT	51.46B	83.11B	84.72B	-25.72B	-20.34B
Effective Tax Rate - (Ratio)	54.97	21.39	17.87	-9.46	-9.1
Total Current Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	30.53B	40.52B	72.09B	-18.24B	-4.32B
Non-Cash Pension Expense	32.79B	10.03B	9.17B	-2B	1.88B
Supplemental Operating Expense Items
Selling and Marketing Expenses	37.71B	41.12B	44.54B	44.61B	44.36B
Research And Development Expense From Footnotes	101B	86.79B	86.29B	78.71B	73.02B

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	225B	342B	287B	262B	227B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	225B	342B	287B	262B	227B
Accounts Receivable, Total	421B	454B	485B	435B	403B
Other Receivables	-	-	-	-	-
Total Receivables	421B	454B	485B	435B	403B
Inventory	293B	263B	310B	299B	270B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	142B	130B	148B	90.71B	91B
Total Current Assets	1,081B	1,189B	1,231B	1,087B	990B
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	401B	438B	418B	389B	280B
Long-term Investments	266B	236B	243B	243B	267B
Goodwill	-	-	-	6.28B	5.42B
Other Intangibles, Total	45.29B	45.11B	42.28B	29.56B	25.66B
Deferred Tax Assets Long-Term	18.3B	19.05B	22.39B	18.13B	21.87B
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	1M	1M	1M	2M	2M
Total Assets	1,812B	1,927B	1,956B	1,773B	1,590B
Liabilities
Accounts Payable, Total	348B	396B	422B	372B	355B
Accrued Expenses, Total	116B	124B	125B	130B	142B
Short-term Borrowings	238B	163B	54.3B	164B	116B
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	-	-	-	18.97B	16.26B
Current Income Taxes Payable	-	-	-	-	-
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	162B	202B	207B	197B	227B
Total Current Liabilities	865B	886B	808B	883B	856B
Long-Term Debt	539B	562B	572B	543B	458B
Pension & Other Post Retirement Benefits	103B	83.56B	73.63B	72.02B	52.91B
Deferred Tax Liability Non Current	-	-	-	-	20.34B
Other Non Current Liabilities	34.4B	32.05B	32.92B	53.29B	45.37B
Total Liabilities	1,541B	1,563B	1,487B	1,551B	1,433B
Common Stock, Total	5B	5B	5B	5B	5B
Additional Paid In Capital	109B	109B	109B	149B	149B
Retained Earnings	247B	290B	345B	59.8B	-90.18B
Treasury Stock	-13.99B	-14.05B	-13.75B	-13.75B	-13.39B
Comprehensive Income and Other	-90.58B	-38.98B	9.48B	8.76B	93.15B
Total Common Equity	257B	351B	455B	209B	143B
Minority Interest	14.39B	13.49B	14.7B	13.62B	14.25B
Total Equity	271B	364B	469B	222B	157B
Total Liabilities And Equity	1,812B	1,927B	1,956B	1,773B	1,590B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	611M	611M	611M	649M	649M
ECS Total Common Shares Outstanding	611M	611M	611M	649M	649M
Book Value / Share	420.02	574.08	744.2	321.5	220.51
Tangible Book Value	211B	306B	412B	173B	112B
Tangible Book Value Per Share	345.87	500.22	674.97	266.29	172.64
Total Debt	776B	725B	627B	726B	590B
Net Debt	551B	383B	339B	464B	363B
Debt Equivalent of Unfunded Proj. Benefit Obligation	95.92B	77.98B	63.34B	65.8B	47.55B
Minority Interest, Total (Incl. Fin. Div)	14.39B	13.49B	14.7B	13.62B	14.25B
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	-	-	-	-	-
Inventories - Raw Materials, Total	68.56B	61.82B	52.14B	50.56B	54.04B
Inventories - Work In Process, Total	67.38B	67.91B	92.51B	76.91B	61.92B
Inventories - Finished Goods, Total	157B	133B	166B	172B	154B
Inventories - Others	1M	1M	1M	-	1M
Land - (BS)	-	-	-	-	-
Buildings, Total	-	-	-	-	-
Machinery, Total	-	-	-	-	-
Full Time Employees	52.88K	50.48K	47.94K	46.2K	43.44K
Accumulated Allowance for Doubtful Accounts (Supple)	2.63B	3.96B	2.34B	3.05B	5.02B

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	32.33B	66.44B	89.8B	-239B	-138B
Depreciation & Amortization - CF	72.63B	71.94B	72.4B	89.8B	66.22B
Depreciation & Amortization, Total	72.63B	71.94B	72.4B	89.8B	66.22B
(Gain) Loss From Sale Of Asset	901M	1.43B	18.17B	215B	120B
(Gain) Loss on Sale of Investments - (CF)	13.47B	2.02B	-278M	121M	1.95B
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	4.08B	16.7B	-3.63B	20.4B	-8.36B
Other Operating Activities, Total	-7.62B	-1.54B	-26.3B	-20.52B	-11.23B
Change In Accounts Receivable	102B	-8.78B	-6.87B	41.58B	56.82B
Change In Inventories	-56.51B	53.27B	-21.47B	45.35B	48.01B
Change In Accounts Payable	-74.37B	15.21B	3.51B	-82.2B	-40.57B
Change in Other Net Operating Assets	-18.23B	-12.05B	-50.17B	-55.44B	29.13B
Cash from Operations	68.45B	205B	75.16B	14.75B	124B
Capital Expenditure	-73.44B	-35.66B	-47.59B	-43.56B	-40.87B
Sale of Property, Plant, and Equipment	5.8B	10.52B	9.22B	9.83B	5.15B
Cash Acquisitions	-2.38B	3.72B	-	-	-166M
Divestitures	-	-	-	-	-364M
Sale (Purchase) of Intangible assets	-20.66B	-15.73B	-15.48B	-13.45B	-11.7B
Investment in Marketable and Equity Securities, Total	-54.05B	-1.89B	-6.1B	-9.48B	47.36B
Other Investing Activities, Total	16.48B	24.91B	28.51B	15.7B	11.47B
Cash from Investing	-128B	-14.11B	-31.45B	-40.97B	10.88B
Short Term Debt Issued, Total	157B	-	-	25.85B	7.44B
Long-Term Debt Issued, Total	1.79B	40.25B	-	1M	11.2B
Total Debt Issued	159B	40.25B	-	25.86B	18.64B
Short Term Debt Repaid, Total	-	-89.4B	-102B	-	-
Long-Term Debt Repaid, Total	-31.6B	-4.69B	-	-10.91B	-157B
Total Debt Repaid	-31.6B	-94.09B	-102B	-10.91B	-157B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-97.08B	-75M	-	-	-
Common & Preferred Stock Dividends Paid	-15.03B	-10.98B	-18.31B	-24.42B	-25M
Common & Preferred Stock Dividends Paid	-15.03B	-10.98B	-18.31B	-24.42B	-25M
Other Financing Activities, Total	-10.87B	-11.83B	-3.49B	-9B	-11.08B
Cash from Financing	4.56B	-76.72B	-124B	-18.48B	-150B
Foreign Exchange Rate Adjustments	-3.24B	8.66B	27.15B	9.86B	26.81B
Miscellaneous Cash Flow Adjustments	1M	-	1M	2.1B	1M
Net Change in Cash	-58.47B	122B	-53.43B	-32.75B	12.52B
Supplemental Items
Cash Interest Paid	4.72B	5.4B	4.45B	8.92B	8.66B
Cash Income Tax Paid (Refund)	10.97B	5.82B	27.42B	13.95B	10.05B
Levered Free Cash Flow	-56.96B	174B	-5.58B	74.94B	80.53B
Unlevered Free Cash Flow	-54.03B	177B	-2.8B	80.75B	87.28B
Change In Net Working Capital	64.72B	-105B	65.07B	-64.04B	-86.35B
Net Debt Issued / Repaid	128B	-53.84B	-102B	14.95B	-139B

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	1.76	2.78	2.73	-0.86	-0.76
Return on Total Capital	3.13	4.86	4.85	-1.57	-1.5
Return On Equity %	4.63	16.45	17.7	-75.66	-79.04
Return on Common Equity	4.59	17.54	18.38	-78.65	-85.24
Margin Analysis
Gross Profit Margin %	17.91	17.37	17.3	12.98	14.98
SG&A Margin	14.59	13.08	13.03	13.32	15.01
EBITDA Margin %	5.49	6.39	6.3	2.51	1.98
EBITA Margin %	2.27	3.43	3.39	-1.01	-0.88
EBIT Margin %	2.27	3.43	3.39	-1.01	-0.88
Income From Continuing Operations Margin %	0.64	2.15	2.96	-10.27	-6.46
Net Income Margin %	0.61	2.2	2.96	-10.24	-6.46
Net Avail. For Common Margin %	0.61	2.2	2.96	-10.24	-6.46
Normalized Net Income Margin	1.35	1.67	2.89	-0.72	-0.19
Levered Free Cash Flow Margin	-2.52	7.17	-0.22	2.94	3.47
Unlevered Free Cash Flow Margin	-2.39	7.31	-0.11	3.17	3.76
Asset Turnover
Asset Turnover	1.24	1.3	1.29	1.37	1.38
Fixed Assets Turnover	5.68	5.78	5.83	6.31	6.94
Receivables Turnover (Average Receivables)	4.77	5.55	5.32	5.54	5.54
Inventory Turnover (Average Inventory)	6.95	7.21	7.2	7.27	6.94
Short Term Liquidity
Current Ratio	1.25	1.34	1.52	1.23	1.16
Quick Ratio	0.75	0.9	0.96	0.79	0.74
Operating Cash Flow to Current Liabilities	0.08	0.23	0.09	0.02	0.15
Days Sales Outstanding (Average Receivables)	76.8	65.8	68.63	65.88	66.01
Days Outstanding Inventory (Average Inventory)	52.65	50.61	50.7	50.17	52.74
Average Days Payable Outstanding	72.73	68.83	70.78	65.7	68.44
Cash Conversion Cycle (Average Days)	56.72	47.59	48.55	50.36	50.31
Long Term Solvency
Total Debt/Equity	286.56	199.08	133.52	326.31	374.69
Total Debt / Total Capital	74.13	66.56	57.18	76.54	78.93
LT Debt/Equity	198.83	154.31	121.95	244.08	290.7
Long-Term Debt / Total Capital	51.43	51.59	52.22	57.25	61.24
Total Liabilities / Total Assets	85.05	81.11	76.01	87.46	90.1
EBIT / Interest Expense	10.96	15.08	19.05	-2.77	-1.88
EBITDA / Interest Expense	26.42	28.14	35.32	6.89	4.25
(EBITDA - Capex) / Interest Expense	10.78	21.67	24.62	2.21	0.46
Total Debt / EBITDA	6.26	4.68	3.99	11.32	12.86
Net Debt / EBITDA	4.44	2.47	2.16	7.23	7.91
Total Debt / (EBITDA - Capex)	15.33	6.07	5.72	35.37	118.02
Net Debt / (EBITDA - Capex)	10.89	3.21	3.1	22.59	72.57
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.53	7.23	2.87	2.1	-8.88
Gross Profit, 1 Yr. Growth %